4//SEC Filing
Elliott Michael James 4
Accession 0001764013-20-000031
CIK 0001764013other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:03 PM ET
Size
5.5 KB
Accession
0001764013-20-000031
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Elliott Michael James
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-09-04+400,000→ 400,000 totalExercise: $36.00Exp: 2030-09-04→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option vest on August 24, 2021, and the remainder vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001822515
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 5:03 PM ET
- Size
- 5.5 KB